...
首页> 外文期刊>Current pharmaceutical design >Lactobacillus rhamnosus GG influences polyamine metabolism in HGC-27 gastric cancer cell line: a strategy toward nutritional approach to chemoprevention of gastric cance.
【24h】

Lactobacillus rhamnosus GG influences polyamine metabolism in HGC-27 gastric cancer cell line: a strategy toward nutritional approach to chemoprevention of gastric cance.

机译:鼠李糖乳杆菌GG影响HGC-27胃癌细胞系中的多胺代谢:一种针对化学方法预防胃癌的营养策略。

获取原文
获取原文并翻译 | 示例
           

摘要

Chemoprevention by dietary constituents has recently emerged as a novel approach to control gastric cancer incidence. Over the past years, functional foods and food supplements, especially probiotics, have received much attention as potential dietary cancer prevention agents. The precise mechanisms by which these lactic cultures exert their antitumorigenic activities are not fully elucidated, but there is some evidence of their influence on cell proliferation and growth. Ornithine decarboxylase (ODC) and spermidine/spermine N1-acetyltransferase (SSAT) are the key enzymes involved in polyamine biosynthesis and catabolism, respectively. These polycationic compounds are significantly associated with cancer risk and represent a specific markers for neoplastic proliferation. The aim of this study was to investigate the effects of increasing concentrations of Lactobacillus rhamnosus strain GG (ATCC 53103) (L. GG) homogenate on polyamine biosynthesis and polyamine degradation as well as on resulting polyamine levels in HGC-27 human gastric cancer cells. The influence of this probiotic on cell proliferation was also evaluated. Administration of probiotic homogenate significantly reduced both ODC mRNA and activity as well as polyamine content and neoplastic proliferation. Besides, an increase in both SSAT mRNA and activity occurred after LGG administration in HGC-27. These data suggest that a nutritional component such as the probiotic L. GG could be proposed in an alternative approach to prevention of gastric cancer. This strategy could overcome the limitations due to a prolonged use of drugs and/or the occurrence of their adverse effects, and it could reasonably also start at a young age.
机译:通过饮食成分进行化学预防最近已成为控制胃癌发生率的一种新方法。在过去的几年中,功能性食品和食品补充剂(尤其是益生菌)作为潜在的饮食性癌症预防剂受到了广泛关注。这些乳酸培养物发挥其抗肿瘤活性的确切机制尚未完全阐明,但是有一些证据表明它们对细胞增殖和生长有影响。鸟氨酸脱羧酶(ODC)和亚精胺/亚精胺N1-乙酰基转移酶(SSAT)是分别参与多胺生物合成和分解代谢的关键酶。这些聚阳离子化合物与癌症风险显着相关,并代表肿瘤增生的特定标记。本研究的目的是研究鼠李糖乳杆菌菌株GG(ATCC 53103)(L. GG)匀浆浓度升高对多胺生物合成和多胺降解以及对人胃癌HGC-27细胞中多胺水平的影响。还评估了该益生菌对细胞增殖的影响。施用益生菌匀浆可显着降低ODC mRNA和活性以及多胺含量和赘生性增生。此外,在HGC-27中施用LGG后,SSAT mRNA和活性均增加。这些数据表明,可以在预防胃癌的另一种方法中提出营养成分,例如益生菌L. GG。这种策略可以克服由于长期使用药物和/或出现其不良反应而引起的局限性,并且可以合理地从年轻开始。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号